Literature DB >> 16325273

No evidence of a significant role for CTLA-4 in multiple sclerosis.

Richard H Roxburgh1, Stephen Sawcer, Mel Maranian, Shaun Seaman, Anke Hensiek, Taiwai Yeo, Jackie Deans, Alastair Compston.   

Abstract

Variation in the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) gene plays a significant role in determining susceptibility to autoimmune thyroid disease and type 1 diabetes. Its role in multiple sclerosis is more controversial. In order to explore this logical candidate more thoroughly, we genotyped 771 multiple sclerosis trio families from the United Kingdom for the 3' untranslated region variable number tandem repeat, the CT60 single nucleotide polymorphism (SNP) and five haplotype-tagging SNPs. No individual marker or common haplotype showed evidence of association with disease. These data suggest that any effect of CTLA-4 on multiple sclerosis susceptibility is likely to be very small.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16325273     DOI: 10.1016/j.jneuroim.2005.10.006

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

Review 1.  Immune checkpoints in central nervous system autoimmunity.

Authors:  Nicole Joller; Anneli Peters; Ana C Anderson; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Alternative splicing in multiple sclerosis and other autoimmune diseases.

Authors:  Irina Evsyukova; Jason A Somarelli; Simon G Gregory; Mariano A Garcia-Blanco
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

Review 3.  Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis.

Authors:  Rodney Stuart; Amy E Lovett-Racke; Elliot M Frohman; Kathleen Hawker; Michael K Racke
Journal:  J Neuroimmunol       Date:  2007-10-24       Impact factor: 3.478

4.  Decreased 4-1BB expression on CD4+CD25 high regulatory T cells in peripheral blood of patients with multiple sclerosis.

Authors:  G-Z Liu; A C Gomes; L-B Fang; X-G Gao; P Hjelmstrom
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

5.  The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease.

Authors:  Lidia Karabon; Agata Kosmaczewska; Malgorzata Bilinska; Edyta Pawlak; Lidia Ciszak; Anna Jedynak; Anna Jonkisz; Leszek Noga; Anna Pokryszko-Dragan; Magdalena Koszewicz; Irena Frydecka
Journal:  Immunology       Date:  2009-02-17       Impact factor: 7.397

Review 6.  The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis.

Authors:  Maria Sofia Basile; Placido Bramanti; Emanuela Mazzon
Journal:  Genes (Basel)       Date:  2022-07-24       Impact factor: 4.141

7.  CNS demyelination associated with immune dysregulation and a novel CTLA-4 variant.

Authors:  Stefania Kaninia; Alexandros Grammatikos; Kathryn Urankar; Shelley A Renowden; Nikunj K Patel; Mark M Gompels; Claire M Rice
Journal:  Mult Scler       Date:  2021-06-07       Impact factor: 6.312

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.